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dimethyl sulphide in culture headspace
Thomas W. E. Chippendale,ab Patrik Sˇpaneˇl,ac David Smith*a and Alicia J. El Haja
A novel, non-invasive technique is reported for determining the numbers of cells in a culture by quantifying
dimethyl sulphide (DMS) in the culture headspace as produced by the cellular enzymatic reduction of
dissolved dimethyl sulphoxide (DMSO). Measured DMS concentrations, as performed using selected ion
ﬂow tube mass spectrometry (SIFT-MS), in the headspace of 2D and 3D cultures of four cell lines, viz.
HEK293 (kidney), MG63 (bone), hepG2 (liver) and CALU-1 (lung), linearly correlate with starting cell
number. Clear diﬀerences in the rates of production of DMS by the four cell types in both the 2D and 3D
situations are seen. This novel analytical technique for cell enumeration oﬀers a signiﬁcant contribution
to quality assessment across cell-based research and industry, including analysis of large scale culture
systems, and for routine cell biology research.1 Introduction
Mammalian cell cultures are involved in a range of applications,
including the production of viral vaccines, recombinant
proteins and cell therapies, as well as for various strands of
biological research. In order to determine the number of cells
present in a culture, be they grown adherently or suspended by
agitation in liquid media, it is usually required that all or a
portion of the cells be removed from the culture vessel for assay.
This can be performed by manually counting the cells using
optical microscopy and bymore complex methods such as MTT-
type colorimetric assays1 or by automated computational image
analysis systems such as Cell-IQ.2 Well-established culturing in
two dimensions (2D) is now being expanded into the three
dimensional (3D) systems in order to mimic physiological
environs, to assess the behaviour of cells in this setting3 and to
develop high-throughput low volume tissue-engineered prod-
ucts for clinical purposes.4 However, sampling of cultures for
cell counting,1,2,5,6 colorimetrics or imaging1 can be challenging
and presents a risk of contamination. Thus, we have investi-
gated whether it is possible to monitor cell viability and
proliferation by analysing in real time the concentrations of
volatile metabolites (VOCs) released by the cells. Direct mass
spectrometric analysis of VOCs emitted by mammalian and
bacterial cells in vitro is a rapidly growing eld that has recently
been thoroughly reviewed.7 A major aspect of this work is to
direct the search and quantication of biomarkers of diseaseedicine – Keele University, Guy Hilton
UK. E-mail: d.smith@keele.ac.uk
Science Park, Keele ST5 5SP, UK
try, Academy of Sciences of the Czech
ech Republic
hemistry 2014and bacterial infection in exhaled breath. This we are pursuing
with some vigour by real time quantication and monitoring of
the VOCs emitted by the common respiratory pathogens Pseu-
domonas aeruginosa,8 Staphylococcus aureus, Streptococcus
pneumoniae and Haemophilus inuenzae9 and Aspergillus
fumigatus.10
The unique cell assay described in this report is based on the
enzymatic conversion of dimethyl sulphoxide (DMSO), one of
the most commonly used amphipathic solvents,11 to volatile
dimethyl sulphide (DMS) in cell cultures by the actions of the
ubiquitous enzyme methionine sulphoxide reductase A (MsrA)
that has been identied in both the mitochondria and the
cytosol of animal cells.12 Thus, it is seen that the rate of DMS
emission from DMSO-spiked cultures, as measured by the
concentration of DMS in the culture headspace, is related to the
number of cells in the culture. This new method of cell
enumeration is analogous to the aforementioned MTT assays
except that the analysis can be performed non-invasively on a
bulk population of cells.2 Experimental
2.1 Cell culture and sample preparation
HEK293 embryonic kidney cells were rst cultured adherently
in tissue culture (T-) asks to conuence in DMEM supple-
mented with 10% foetal bovine serum (PBS), 2 mM L-glutamine
and 1% penicillin–streptomycin. For 2D experiments, cells were
removed using trypsin, counted and transferred to T75 asks
(300 mL total volume) in 15 mL of medium additionally sup-
plemented with 0.1% v/v DMSO and 10 mM HEPES. For 3D
experiments, cells were removed, counted and seeded to
hydrogels of rat tail collagen I (3 g L1; BD Biosciences). The gels
were formed by neutralising the acetic acid–collagen solutionAnalyst, 2014, 139, 4903–4907 | 4903
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View Article Onlineusing 1M sodium hydroxide and adding 10 PBS (10%), the cell
suspension (in culture medium; 10%), DMSO (0.1%) and sterile
deionised water. The mixture was sealed inside clean, sterile 10
mL glass containers and allowed to set for approximately 30
minutes before a further 1 mL of culture medium containing
0.1% DMSO and 10 mM HEPES was added. In both 2D and 3D
experiments, the T75 asks and the glass vessels were sealed
with septa-caps and incubated at 37 C for 16 hours, aer which
the headspace above the cells was analysed for trace volatile
compounds using selected ion ow tube mass spectrometry
(SIFT-MS; see below). These methods are adapted from cell
culture headspace analysis methods developed by our group
previously.3,13,14
Three other cell lines, namely MG-63, hepG2 and CALU-1,
were included in this study. In the 2D experiments, following
the initial culture in T-asks, the cells were transferred to
150 mL glass bottles, sealed using septa caps and incubated
overnight at 37 C in media (DMEM with 10% FBS, 2 mM
L-glutamine and 1% penicillin–streptomycin) containing 0.1%
DMSO and 100 mM HEPES. This method more closely follows
the previously published work wherein the headspace of cell
cultures was analysed for volatile organic compounds using
SIFT-MS.3,13,14 The 3D cultures were prepared in the manner
described above and the headspace again analysed by SIFT-MS.2.2 Headspace analysis by SIFT-MS
The SIFT-MS analytical technique can be used to quantify, in
real time, several trace gas compounds in gaseous, humid
samples; it has been described previously in several review
articles.15–17 Briey, a mixture of ions is generated by a micro-
wave discharge through humid air, and a desired ionic species
is selected from the mixture using a quadrupole mass lter and
injected into the owing helium carrier gas of the SIFT-MS
instrument to act as precursor (reagent) ions for the analysis.
Concurrently, the sample vapour (headspace) to be analysed is
introduced into the carrier gas via a calibrated, heated capillary
at a known ow rate, when the composite trace compounds of
the sample undergo reactions with the injected reagent ions.
The product (analyte) ions of these analytical reactions are
sampled into a downstream quadrupole mass spectrometer,
where a signal is generated in terms of ion counts-per-second
(c s1). The reagent ions employed in SIFT-MS are always H3O
+,
NO+ or O2
+_; these have been chosen because they do not react
signicantly with the major compounds of air (nitrogen,
oxygen, argon), and so only the trace gas compounds are reac-
tive and can be analysed. When the reaction kinetics (rate
coeﬃcients and product ions) of each trace compound are fully
characterised, their concentrations can be obtained.
In order to perform an analysis, the cell culture headspace it
is sampled by piercing the septa that close the culture
containers with a hypodermic needle attached to the sampling
arm of the SIFT-MS instrument. In the present experiments, the
DMS concentration in the headspace matrix was determined
with NO+ reagent ions from the count rates of the m/z 62 iso-
topologue of the product ion (CH3)2S
+ as described previ-
ously.18,19 It should be noted that due to the sample ow rate4904 | Analyst, 2014, 139, 4903–4907(30 mL min1) and the relatively small headspace volume of
the vessels used to perform the 3D experiments (8 mL), it was
necessary to balance the atmospheric pressure inside the
bottles by using a ow of clean cylinder air from a exible bag
coupled to the bottle via a second hypodermic needle. The nite
dilution of the headspace sample due to this procedure can
readily be accounted for by extrapolation of the analytical curve
to the onset of sampling.20 This sampling procedure has been
described in detail in previous publications.3,13,14,21,22
2.3 Colorimetric cell counting assay
Following the headspace analysis by SIFT-MS, the total cell
number in the culture was assessed by the water-soluble tetra-
zolium salt WST-8 assay23 using Cell Counting Kit-8 (CCK-8; NBS
Biologicals). Due to the relatively large volumes of the cell
samples and the presence of the collagen in the 3D experi-
ments, the protocol was modied from that recommended by
the manufacturer. To the T75 cultures used for the 2D experi-
ments (15 mL liquid volume), 150 mL of CCK-8 solution was
added and the vessels were incubated for 1 hour at 37 C. To the
10 mL vessels containing the 3D collagen scaﬀold cultures,
40 mL of CCK-8 solution was added, and the vessels were incu-
bated for 4 hours. In each case, following the incubation period,
100 mL media samples were extracted from the cultures and
transferred to a 96-well plate (n ¼ 3). A Synergy 2 spectropho-
tometer (BioTek) was then used to measure the absorbance of
the samples at 450 nm, with the absorbance at 650 nm sub-
tracted, as recommended by the manufacturer. The absorbance
reading at 450 nm correlates with the production of formazan
dye by the cells that, in turn, is related to both the number of
viable cells in the sample and to the metabolic activity of the
cells.
3 Results & discussion
3.1 Non-cytotoxicity of DMSO
This novel approach to cell number assessment obviously
requires that the toxicity of DMSO be addressed if the proposed
method is to be utilized. DMSO is commonly used as a cry-
opreservant for human cells at a concentration of 10% v/v (ref.
24) and is used clinically as a palliative treatment for interstitial
cystitis.25 A study by our group revealed no change in the
viability of both primary human bone marrow-derived mesen-
chymal stem cells (MSCs) and hepG2 hepatocyte-like cells
following 16 hours incubation in medium containing 0.1%
DMSO.21 In addition, a study by Da Violante and co-workers
found no signicant cytotoxic eﬀects in Caco2/TC7 colon
tumour cells cultured with DMSO concentrations of up to
10%.24 Whilst these data are persuasive as far as they go, more
work is desirable to fully validate the non-toxicity of DMSO at
the low concentrations needed for this novel cell assay method.
3.2 HEK293 embryonic kidney cells
3.2.1 2D cultures. DMS concentrations were measured in
the headspace of sealed HEK293 cultures following 16 hours of
incubation at 37 C in media containing DMSO at the lowThis journal is © The Royal Society of Chemistry 2014
Table 1 The mean DMS production rates, given in molecules per cell
per minute, of four established cell lines, HEK293, MG-63, hepG2 and
CALU-1, cultured in 2D and 3D systems. The HEK293 cells were
cultured in T75 ﬂasks (95% headspace) for the 2D experiments and
10 mL glass containers (80% headspace) for the 3D experiments. The
MG-63, hepG2 and CALU-1 cells were each cultured inside 150 mL
vessels (90% headspace). These were sealed and incubated for 16
hours prior to headspace analysis by SIFT-MS
Cell type
Mean DMS production rate (106
DMS molecules per cell per min)
2D 3D
HEK293 Embryonic kidney 0.89 0.44
MG-63 Osteoblast-like 3.2 4.2
hepG2 Hepatocyte-like 0.99 0.67
CALU-1 Lung epidermoid 9.9 1.8
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View Article Onlinenon-toxic concentration of 0.1% using SIFT-MS.15–17 Due to the
volatility of DMS, it is distributed between both the gas and
liquid phases in equilibrated proportions that are readily
determined. For example, the headspace of the T75 asks used
to conduct the 2D experiments described in this study
accounted for 95% of the total volume of the vessel, which
according to Henry's Law considerations for DMS26 reveals that
71% of the total DMS in the system was contained as gas in the
headspace. The headspace of the 10 mL containers used to
conduct the 3D experiments accounted for 80% of the total
volume and contained only 34% of the DMS. Thus, an accurate
value for the molecular production rate by the cells can be
determined by calculating the sum of the rates of emission into
both the liquid and vapour phases.
The plot in Fig. 1A shows the results obtained for 2D (sealed
T75 tissue culture asks) cell cultures for the DMS concentra-
tions in ppbv as a function of the starting cell number density.
The linearity of the plot suggests that cell number can be
accurately derived using this non-invasive method. Given the
gas and liquid phase volumes, the incubation period and the
Henry's Law coeﬃcient of DMS,20,26 the mean DMS production
rate of the HEK293 cells can be determined from the slope of
the line in this gure. Thus, the mean production rate for these
2D cultures is 8.9 105 DMSmolecules per cell per minute (also
given in Table 1). Immediately following the analyses by SIFT-
MS, the cell numbers were counted by the established WST-8-
based colorimetric assay as mentioned above, which addition-
ally provides an indication of metabolic activity23 as discussed
in Section 2.3. Once again, a linear relationship between the
absorbance readings and cell count was obtained as shown in
Fig. 1B, but in this case note the relatively large intercept on the
absorbance axis indicating the “background” absorbance of the
phenol red that is present in the culture medium. More
importantly, as the starting cell number density doubles the
relative increase in the absorbance is small, of the order of 10%
only, which in some cases is barely within the error of the
measurements, whereas the increase in headspace DMS
concentration clearly indicates the greater sensitivity of the
DMSO/DMS method of cell enumeration. Nonetheless, given
the linear relationships in Fig. 1A and B, the equivalence of
these two diﬀerent assays is clear for cells cultures in the 2DFig. 1 (A) DMS concentrations, given in parts-per-billion by volume of he
culture ﬂasks (2D cultures) following incubation for 16 h at 37 C, plotte
uncertainty of the mean of 3 DMS concentrations. (B) Absorbance meas
obtained from the WST-8-based cell counting assay performed immedi
This journal is © The Royal Society of Chemistry 2014situation, but this DMS method has the distinct advantage that
it is completely non-invasive, given that the DMSO is seemingly
non-toxic at the 0.1% v/v level, and the culture need not be
manipulated.
3.2.2 3D cultures. The DMS production of HEK293 cells in
3D cultures contained inside sealed 10 mL glass vessels in 1 mL
of rat tail collagen type I with 1 mL of medium is again linearly
related to the seeding cell number density, as can be seen in
Fig. 2A. It was observed (see Table 1) that the rate of production
of DMS is about two times slower that in the 2D culture; this
could possibly be explained by interactions between the DMSO
or DMS with the collagen scaﬀolds, inhibiting the DMSO from
making contact with the cells. However, the plot obtained for
the WST-8 absorbance against initial cell number is far from
linear, as can be seen in Fig. 2B, which reveals a slow increase at
low cell number that rapidly increases at higher cell numbers.
The overall metabolic activity of the cells is known to inuence
expression of the dehydrogenase and other reductase enzymes
that underpin WST-8 and similar colorimetric assays. There-
fore, a likely explanation for the shape of the curve in Fig. 2B is
that the cells cultured at the highest seeding density were
simply more metabolically active. Note again the background
absorbance due to the medium/collagen alone caused by the
presence of phenol red in the culture medium. Once again, atadspace (ppbv), measured in HEK293 cultures inside sealed T75 tissue
d against the starting cell number density. The error bars indicate the
urements at 450 nm (background absorbance at 650 nm subtracted)
ately after the SIFT-MS headspace analysis.
Analyst, 2014, 139, 4903–4907 | 4905
Fig. 2 (A) DMS concentrations, given in parts-per-billion by volume of headspace (ppbv), measured in HEK293 cultures sealed in 10 mL glass
vessels containing 1 mL of medium and 1 mL of rat tail collagen type I (3D cultures) following incubation for 16 h at 37 C, plotted against the
starting cell number density. (B) Absorbance measurements at 450 nm (background absorbance at 650 nm subtracted) obtained from the WST-
8-based cell counting assay performed immediately after the SIFT-MS headspace analysis. The error bars indicate the uncertainty of the mean of
3 DMS concentrations. The dashed line in (B) is an “eye-ball” variation following the data points.
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View Article Onlinethe lower starting cell number densities (0–0.27  106 cells
mL1) the relative increase in the absorbance measurement as
the cell number density is doubled is only 10–20%, whereas the
increase in DMS headspace concentration approximately
doubles. This increase in sensitivity suggests that the new
DMSO/DMS reduction method can be superior to WST-8 and
other MTTs for measuring cell number, especially in 3D
cultures. What is exciting is that the combination of these
methods can provide further insight into the behaviour of the
cells in the 3D situation, perhaps providing additional infor-
mation on the metabolic activities of the cells.3.3 MG-63, hepG2 and CALU-1 cell lines
3.3.1 2D cultures. The rates of DMS production for three
other cell lines, viz.MG-63 osteoblast-like, hepG2 hepatocyte-like
and CALU-1 lung epidermoid carcinoma cells, cultured in 2D
have also been derived; these are shown in the Table 1. These cell
types have relevance to studies of bone implantology, liver
disease and lung cancer respectively. Headspace analyses of DMS
were performed as before for each of the cell lines contained
inside sealed 150mL vessels. Over the 16 hour incubation period,
the MG-63 and CALU-1 cells produced DMS at a faster mean rate
than the HEK293 cells, whilst production by the hepG2 cells was
comparable with that of HEK293, but production rates of all four
cell types were within an order of magnitude of 106 DMS mole-
cules per cell per minute. It is also perhaps signicant that the
twomost proliferative cell typesMG-63 and CALU-1 produce DMS
most rapidly. These collected data indicate that DMS production
is cell specic and when the rate of production of DMS in a
specic medium has been determined for a particular cell type
then it can be exploited to non-invasively determine the number
of the cells in the 2D culture.
3.3.2 3D cultures. The rates of production of DMS by these
three cell lines cultured in 3D are also given in Table 1. It can be
seen that for MG-63 the emission of DMS into the gas phase was
more rapid when the cells were cultured in 3D compared to 2D,
whereas the opposite is true for the CALU-1 cells. In fact, the
DMS production rate by CALU-1 cells was more than 5 times
greater when cultured in 2D compared to 3D. These results
suggest that the interaction between the cells and the growth
surface/matrix is an important factor in determining the rate of4906 | Analyst, 2014, 139, 4903–4907DMS production. However, whether this is due to the metabolic
state of the cells or a result of changes in the actual number of
cells is a question that requires further investigation. Again, it is
important to note that the volatility of DMS from aqueous
solution is very high, so the volume of the liquid/collagen is not
very important is establishing the headspace DMS concentra-
tion vis-a`-vis the liquid phase concentration, since almost all
the DMS generated by the cellular reduction of DMSO appears
in the gaseous phase above the culture.4 Concluding remarks
The experimental data presented in this short paper demon-
strate that the measurement of headspace DMS concentration
produced from DMSO by the cells can be a valuable non-inva-
sive technique by which the number of cells in both 2D and 3D
cultures can be determined. Indeed, its combination with the
conventional assays may oﬀer further insights into the behav-
iour of cells in the 3D situation. This new technique is appli-
cable to cell and biochemical engineering applications as well
as to tissue engineering and generic cell biological research. In
fact, it has been hypothesised that the activity of the DMSO-
reducing enzyme MsrA could be employed as a stem or
progenitor cell marker for the isolation of cell populations.27
Given the presence of DMSO-reducing enzymes in a variety of
prokaryotic and eukaryotic cells, the technique might also be
applicable for monitoring the growth of microbial cell cultures
in biopharmaceutical production processes. Thus, this novel
approach appears to be promising for further application in a
variety of biological elds.Competing ﬁnancial interests
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